Related Experiment Video
Updated: May 16, 2025
A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
Published on: March 28, 2021
Identification of a new small Rho GTPase inhibitor effective in glioblastoma human cells
Angela Parise1, Ivana Manini2, Enrico Pobega3
1Consiglio Nazionale delle Ricerche (CNR)-IOM, c/o International School for Advanced Studies (SISSA/ISAS), via Bonomia 265, 34136, Trieste, Italy.
Abstract:
Glioblastoma (GBM) is the most common and lethal primary brain tumour. The prognosis for GBM patients remains poor due to rapid tumour recurrence and resistance to conventional treatments. Small Rho GTPase proteins, which regulate cell shape and motility, are critical for GBM aggressive growth and infiltration into the surrounding brain parenchyma. Hence, small-molecule inhibitors targeting them represent an appealing opportunity to hinder the infiltration behaviour of GBM. Here, a synergistic experimental and computational approach allowed us to identify an inhibitor that reduces migration in patient-derived GBM cell lines. Computational and in vitro functional assays reveal that this compound inhibits Rho GTPases function by targeting multiple allosteric sites thereby enhancing flexibility of key functional regions and hindering their interaction with protein regulators. Our research unveiled a novel hit molecule targeting Rho GTPases with significant potential to improve the treatment of GBM and other highly aggressive tumours.
Insights
Researchers identified a novel small molecule inhibitor targeting Rho GTPases to reduce glioblastoma cell migration. This discovery offers a promising new therapeutic strategy for glioblastoma (GBM) and other aggressive cancers.
Area of Science:
- Oncology
- Molecular Biology
- Drug Discovery
Background:
- Glioblastoma (GBM) is an aggressive primary brain tumor with poor patient prognosis.
- Tumor recurrence and treatment resistance are major challenges in GBM management.
- Small Rho GTPase proteins are crucial regulators of GBM cell motility and invasion.
Purpose of the Study:
- To identify and characterize novel small-molecule inhibitors targeting Rho GTPases for GBM treatment.
- To evaluate the efficacy of identified inhibitors in reducing GBM cell migration and infiltration.
Main Methods:
- Synergistic application of computational modeling and experimental assays.
- In vitro functional assays using patient-derived GBM cell lines.
- Analysis of compound interaction with Rho GTPases at allosteric sites.
Main Results:
- Identification of a novel small-molecule inhibitor that effectively reduces GBM cell migration.
- Demonstration that the compound inhibits Rho GTPase function by targeting multiple allosteric sites.
- Evidence of enhanced flexibility in key functional regions, hindering protein-regulator interactions.
Conclusions:
- A novel hit molecule targeting Rho GTPases has been discovered.
- This inhibitor shows significant potential for improving GBM treatment by hindering tumor cell infiltration.
- The findings suggest broader applicability for treating other aggressive tumors.
More Related Videos
08:11A Simple Guide Screw Method for Intracranial Xenograft Studies in Mice
Published on: September 26, 2011
10:28Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
Published on: January 10, 2018
